10X GENOMICS DL -00001
10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related… Read more
10X GENOMICS DL -00001 (1KJ) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, 10X GENOMICS DL -00001 (1KJ) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
10X GENOMICS DL -00001 - Net Assets Trend (None–None)
This chart illustrates how 10X GENOMICS DL -00001's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for 10X GENOMICS DL -00001 (None–None)
The table below shows the annual net assets of 10X GENOMICS DL -00001 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to 10X GENOMICS DL -00001's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
10X GENOMICS DL -00001 Competitors by Market Cap
The table below lists competitors of 10X GENOMICS DL -00001 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hunan Changyuan Lico Co Ltd
SHG:688779
|
$1.69 Billion |
|
Nations Technologies Inc
SHE:300077
|
$1.69 Billion |
|
SilverCrest Metals Inc
NYSE MKT:SILV
|
$1.69 Billion |
|
Blue Bird Corp
NASDAQ:BLBD
|
$1.70 Billion |
|
Dunelm Group plc
F:DFQ
|
$1.69 Billion |
|
Vivendi SA PK
PINK:VIVHY
|
$1.69 Billion |
|
Vivendi SE
PINK:VVVNF
|
$1.69 Billion |
|
Top Choice Medical Investment Co Inc
SHG:600763
|
$1.69 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in 10X GENOMICS DL -00001's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares 10X GENOMICS DL -00001's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently 10X GENOMICS DL -00001 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares 10X GENOMICS DL -00001's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $1,807,324,866
- Average return on equity (ROE) among peers: -12.22%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| 10X GENOMICS DL -00001 (1KJ) | €- | N/A | N/A | $1.69 Billion |
| Schrödinger, Inc. (43Z) | $557.09 Million | -18.02% | 0.36x | $631.00 Million |
| DACHA STRATEGIC (7DC) | $40.24 Million | 0.65% | 0.08x | $81.97 Million |
| ABL Diagnostics Société anonyme (9BK0) | $6.77 Million | 0.80% | 1.20x | $371.65K |
| Zhejiang Taimei Medical Technology Co., Ltd. (A2V) | $1.04 Billion | -33.28% | 0.39x | $47.71 Million |
| ASCOM HLDG NA SF 0,50 (AH2N) | $80.00 Million | 16.88% | 1.43x | $190.62 Million |
| DocCheck AG (AJ91) | $18.14 Million | 3.32% | 0.15x | $18.00 Million |
| EM Systems Co. Ltd (EMO) | $17.69 Billion | 7.87% | 0.33x | $74.55 Million |
| Tempus AI (F3M) | $-1.38 Billion | 0.00% | 0.00x | $4.75 Billion |
| Pangenomic Health Inc. (LL3) | $2.24 Million | -118.14% | 0.15x | $4.82 Million |
| MeVis Medical Solutions AG (M3V) | $17.83 Million | 17.76% | 0.45x | $12.89 Million |